Medicine
TachoSil 5.5 mg/2 units patch
TachoSil 5.5 mg/2 units patch is a prescription medicine containing Fibrinogen human and Human thrombin for topical use, marketed by Corza Medical, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
TachoSil does not require refrigeration. Do not freeze. Store unopened…
Key facts
- Active ingredient (INN)
- Fibrinogen human and Human thrombin
- Brand
- TachoSil
- Strength
- 5.5 mg/2 units
- Dosage form
- Patch
- Route
- Topical
- Packs
- 1 pouch, 2 pouches
- Marketing authorisation holder
- Corza Medical
- Manufacturer
- Corza Medical
- Origin register
- US FDA, United States
- Storage
- TachoSil does not require refrigeration. Do not freeze. Store unopened packages of TachoSil between 2ºC and 25ºC.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.12Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 August 2025
- Identifiers
- RxCUI 1001591, 1001593, 1014303 +1DailyMed set ID 0c324332-290f-413f-820c-8c9a971a2766NDC 83078-702, 83078-704, 83078-701Application BLA125351
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 pouch in 1 carton / 1 blister pack in 1 pouch / 1 patch in 1 blister pack | 83078-701-01 | Corza Medical | 29 August 2025 |
| 2 pouch in 1 carton / 1 blister pack in 1 pouch / 1 patch in 1 blister pack | 83078-702-02 | Corza Medical | 29 August 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Fibrinogen human and Human thrombin
Clinical summary
Fibrinogen human and Human thrombin is a fixed-dose combination medicine indicated with manual compression in adult, among other approved uses. It is available as topical solution and patches. MedsAcross supplies Fibrinogen human and Human thrombin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Fibrinogen human and Human thrombinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TachoSil prescribing information (Corza Medical) · U.S. National Library of Medicine, DailyMed
Need TachoSil 5.5 mg/2 units patch for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.